Hi McQuade
I can understand your frustration with PET. I am also a holder and I also hold AVH. The similarities are incredible that have both been around a long time both on the verge of going into profit, even more so with PET. Both have had directors sell share which scares investors. AVH does make money about 4.6 Million a quarter. And PET does similar but I don't know how all that balance sheet stuff works I have trouble understanding it.
But I know that make around that much. Both got upgraded to the ASX 300 at the same time and both have had large % pull backs. AVH has already recovered from its first pull back in April and is now going through a second one. I think recovering from a pull back gives Investors confidence.
In my own opinion PNV hasn't recovered from this pull back yet which is keeping people on the sidelines.
Im confident PNV will recover it is a matter of how long will it take?
AVH makes about 4.6 million a quarter but they choose to spend more than that to grow which is why they had a cap raise. PNV I think is one step ahead with income coming in. I think it is enough to grow without another cap raise, but this what I understand from what I have read, I'm no expert.
So I will wait, PNV is a long term hold for me but I think it is going through a test at the moment. I don't know how long it will take for confidence to return but I think it will.
Good news is not enough I have found, the good news has to have dollars attached to it. And PNV has had lots of good news now we need $ signs attached and the confidence will return.
cheers good luck PNV investors from noeinsteon.
- Forums
- ASX - By Stock
- Predatory Shorting
PET
phoslock environmental technologies limited
Add to My Watchlist
0.00%
!
2.5¢

Hi McQuade I can understand your frustration with PET. I am also...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
2.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.60M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
PET (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online